Top Markets
Coin of the day
BELLUS Health Inc. BELLUS Health Inc.

BELLUS Health Inc.

BLU
株式のランク #6896
BELLUS Health Inc. is a biopharmaceutical firm in the clinical development... BELLUS Health Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to creating new therapeutic options for intractable chronic cough (RCC) and various other conditions characterized by heightened cough sensitivity. The company's primary investigational compound, BLU-5937, functions as a P2X3 receptor antagonist. This drug is currently progressing through Phase II clinical trials, where it is being assessed for its potential in treating both RCC and persistent itching. Founded in 1993, BELLUS Health Inc. is headquartered in Laval, Canada.
株価
$14.30
最終同期: 2023-06-29
時価総額
$1.81B
変化(1日)
-2.81%
変化(1年)
0.00%
CA
取引 BELLUS Health Inc. (BLU)

カテゴリー

BELLUS Health Inc.(BLU)の株価履歴
終値の最高値: $14.62 (2023-06-01)

終値の最安値: $617.12 (2000-06-01)
BELLUS Health Inc. の株価履歴(2000 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2023 56.80%
2022 31.13%
2021 132.06%
2020 -56.49%
2019 141.94%
2018 161.76%
2017 54.42%
2016 -72.16%
2015 -39.98%
2014 212.05%
2013 -6.93%
2012 -69.52%
2011 -61.15%
2010 -32.03%
2009 -57.70%
2008 -83.40%
2007 -89.98%
2006 82.43%
2005 -27.25%
2004 -7.64%
2003 313.71%
2002 87.44%
2001 -57.20%
2000 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$548.36 39.87%
US
$1.06K 50.29%
NL
$121.16 -12.75%
AU
$140.81 475.44%
US
$765.25 7.74%
CH